Prevalence and Profile of Aspirin Resistance in Hemodialysis Patients
NCT ID: NCT00792272
Last Updated: 2013-07-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
100 participants
OBSERVATIONAL
2008-06-30
2008-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prevalence of Aspirin Resistance in Chronic Kidney Disease Patients
NCT01364779
Aspirin to Target Arterial Events in Chronic Kidney Disease
NCT03796156
The Effect Of Aspirin On Survival in in Patients Undergoing Chronic Hemodialysis
NCT02261025
Aspirin in the Prevention of Cardiovascular Events in Hemodialysis Patients
NCT01198379
Whole Blood Platelet Aggregation in Chronic Kidney Disease Patients on Aspirin Study
NCT01768637
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* coagulopathy, bleeding disorders
* patient on plavix
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Staten Island University Hospital
OTHER
Northwell Health
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Suzanne El-Sayegh
Assoc. Chair of Medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Suzanne El-Sayegh, MD
Role: PRINCIPAL_INVESTIGATOR
SIUH
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
08-013
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.